Evaluation of development of subclinical atherosclerosis in children with uveitis

Seçil Conkar1, Suzan Güven Yılmaz2, İlker Özgür Koska3

  • 1Department of Pediatric Nephrology, Ege University Faculty of Medicine, İzmir, Turkey. secilcankar@yahoo.com.tr.

Clinical Rheumatology
|July 12, 2017
PubMed

Insights

Children with uveitis show early signs of atherosclerosis, including increased arterial stiffness and augmentation index. Longer disease duration correlates with more advanced subclinical atherosclerosis markers.

Area of Science:

  • Pediatric Rheumatology
  • Cardiovascular Research
  • Ophthalmology

Background:

  • Uveitis is a chronic inflammatory condition linked to atherosclerosis development.
  • Atherosclerosis, a major cardiovascular disease risk factor, can begin in childhood.
  • Investigating subclinical atherosclerosis in children with uveitis is crucial for early detection and intervention.

Purpose of the Study:

  • To assess subclinical atherosclerosis in children diagnosed with uveitis.
  • To compare arterial stiffness and carotid artery intima-media thickness (cIMT) between uveitis patients and healthy controls.
  • To explore the relationship between uveitis duration and atherosclerosis markers.

Main Methods:

  • Seventy-five children with uveitis and 50 healthy controls were included.
  • Exclusion criteria: hypertension, obesity, dyslipidemia, diabetes, and prior cardiovascular disease.
  • Measurements included carotid-femoral pulse wave velocity (PWV), augmentation index (AIx), and cIMT.

Main Results:

  • Patients with uveitis exhibited higher PWV and AIx compared to controls (p=0.04, p=0.03).
  • No significant difference in cIMT was observed between groups initially.
  • Children with uveitis duration >5 years showed elevated PWV, AIx, and cIMT (p<0.05).

Conclusions:

  • Children with uveitis demonstrate early vascular dysfunction and subclinical atherosclerosis.
  • Prolonged uveitis duration exacerbates atherosclerosis markers, including cIMT.
  • Non-invasive atherosclerosis markers are recommended for monitoring uveitis progression and treatment efficacy.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
629
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
776
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
512
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
527
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
679